Towards a sustainable and integrated development and implementation of new prophylactic vaccines

It is generally accepted that vaccines designed to prevent infectious diseases are one of the most cost-effective health care interventions. In this reflection paper, we discuss the need for investment and development of prophylactic vaccines, particularly in light of increasing regulatory requirements, pressure on healthcare spending and the tendency towards vaccines commoditisation. Access it here.